RetiPharma IVS

CVR 37134120 · Entrepreneurial company (IVS) · Dissolved after voluntary liquidation

RetiPharma IVS is a Entrepreneurial company (IVS), founded on , based in København N. The company is registered in the industry anden teknisk rådgivning. The company is no longer active (status: dissolved after voluntary liquidation). 3 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2018) shows equity of DKK -190k and a net result of DKK -204k.

Company details

CVR number
37134120
Status
Dissolved after voluntary liquidation
Company type
Entrepreneurial company (IVS)
Founded
Ceased
Address
Ole Maaløes Vej 3
2200 København N
Municipality
København
Industry
Anden teknisk rådgivning (711290)
Bankruptcies in the industry: Uoplyst
Share capital
DKK 6,816
Employees
4 (2018)
Auditor
inforevision, Statsautoriseret Revisionsaktieselskab
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 0
Missing annual reportYes
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address3
Going-concern uncertaintyNo

Financials and key figures

Financial year20182017
Gross profitDKK -147kDKK 0
Net profitDKK -204kDKK 0
EquityDKK -190kDKK 1
Total assetsDKK 6.6mDKK 1
CashDKK 5.1m–
Short-term debtDKK 471k–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · inforevision, Statsautoriseret Revisionsaktieselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2018 – 31 Dec 2018154
1 Jan 2017 – 31 Dec 2017135
10 Sep 2015 – 31 Dec 2016314 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOKristian Klemp
CEOKristian Klemp
BoardJørgen Axel Thorball
BoardCasper Tind Hansen
BoardMorten Albrechtsen
BoardDavid Paul Drucker Woldbye
Owner (20%)Kristian Klemp
Owner (20%)David Paul Drucker Woldbye
Owner (20%)Casper René Mahajan Gøtzsche
Owner (5%)Anders Tolstrup Christiansen
Owner (10%)WEXOTEC ApS
Owner (5%)Andreas Toft Sørensen
Auditorinforevision statsautoriseret revisionsaktieselskab
FounderKristian Klemp
FounderDavid Paul Drucker Woldbye

Address history (1 moves)

Ole Maaløes Vej 3, 2200 København N
c/o David Woldbye, Slagelsegade 6, 2., 2100 København Ø

Former names

RetiPharma IVS –
RetiCare IVS –

Employees per year

Number of employees at RetiPharma IVS per year242018: 42018

Other companies at the same address

Similar companies in København

Questions and answers about RetiPharma IVS

Has RetiPharma IVS gone bankrupt?

No, RetiPharma IVS is not registered as bankrupt in the CVR register. Its status is: dissolved after voluntary liquidation.

Who is the auditor of RetiPharma IVS?

RetiPharma IVS most recently used inforevision, Statsautoriseret Revisionsaktieselskab.

When was RetiPharma IVS founded?

RetiPharma IVS was founded on 10 September 2015.

What is the equity of RetiPharma IVS?

Equity was DKK -190k according to the annual report for the period ending 31 December 2018.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.